Another Incretin Drug Proves Mettle in Sleep Apnea
4 Articles
4 Articles
Another Incretin Drug Proves Mettle in Sleep Apnea
(MedPage Today) -- Treatment with the novel triple agonist retatrutide improved obstructive sleep apnea (OSA) in adults with obesity or overweight regardless of type 2 diabetes, two parallel randomized clinical trials showed. Mean reduction in...
The retatrutide, an experimental molecule used in tests to check the efficiency of obesity treatments, can alleviate the symptoms caused by sleep apnea. It is what points to two international studies published on Wednesday (21) in The New England Journal Of Medicine. Also known as SAOS (Sleep Obstructive Apnea Syndrome), the condition occurs when airways become blocked during sleep, causing interruptions in breathing. The condition is often asso…
Retatruid reduced the frequency of obstructive apnea in sleep at excess body weight
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
